Related references
Note: Only part of the references are listed.Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis
Rish K. Pai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Mediators of the Resolution of the Inflammatory Response
Michelle A. Sugimoto et al.
TRENDS IN IMMUNOLOGY (2019)
IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease
Lyssia Belarif et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
Antonio Recchiuti et al.
FRONTIERS IN PHARMACOLOGY (2019)
Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis
Christopher S. Smillie et al.
CELL (2019)
Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy
Jerome C. Martin et al.
CELL (2019)
Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD
Hong Liu et al.
BMC IMMUNOLOGY (2019)
Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions
Nan Chiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Recruitment of activated neutrophils correlates with disease severity in adult Crohn's disease
A. Therrien et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing
Veronika Butin-Israeli et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Alexander R. Moschen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Effect of vedolizumab (anti-alpha 4 beta 7-integrin) therapy on histological healing and mucosal gene expression in patients with UC
Ingrid Arijs et al.
GUT (2018)
Resolvins suppress tumor growth and enhance cancer therapy
Megan L. Sulciner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
T-lymphocyte-derived enkephalins reduce T(h)1/T(h)17 colitis and associated pain in mice
Lilian Basso et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease
Alpdogan Kantarci et al.
EXPERIMENTAL NEUROLOGY (2018)
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Charles N. Serhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
Siddharth Singh et al.
JOURNAL OF CROHNS & COLITIS (2018)
Resolvin E1, but not resolvins E2 and E3, promotes fMLF-induced ROS generation in human neutrophils
Yuka Unno et al.
FEBS LETTERS (2018)
Resolution of chronic inflammatory disease: universal and tissue-specific concepts
Georg Schett et al.
NATURE COMMUNICATIONS (2018)
MAbTope: A Method for Improved Epitope Mapping
Thomas Bourquard et al.
JOURNAL OF IMMUNOLOGY (2018)
Effects of Anti-Tumor Necrosis Factor Use on Colorectal Cancer Outcomes in Patients with Inflammatory Bowel Disease
William Y. Luo et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2018)
Development and validation of a histological index for UC
Mahmoud H. Mosli et al.
GUT (2017)
Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes
Marcelo O. Freire et al.
JOURNAL OF IMMUNOLOGY (2017)
Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection
Thomas Gobbetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
Olaf Eickmeier et al.
PLOS ONE (2017)
Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis
Chun-Teh Lee et al.
JOURNAL OF IMMUNOLOGY (2016)
Resolution of inflammation: a new therapeutic frontier
James N. Fullerton et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Resolution of inflammation: what Controls its Onset?
Michelle A. Sugimoto et al.
FRONTIERS IN IMMUNOLOGY (2016)
Resolution of inflammation is altered in Alzheimer's disease
Xiuzhe Wang et al.
Alzheimers & Dementia (2015)
ChemR23, the Receptor for Chemerin and Resolvin E1, Is Expressed and Functional on M1 but Not on M2 Macrophages
Magdalena Herova et al.
JOURNAL OF IMMUNOLOGY (2015)
Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters
Kishore Cholkar et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Impact of colonic mucosal lipoxin A4 synthesis capacity on healing in rats with dextran sodium sulfate-induced colitis
Erol R. Agis et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Comparing histological activity indexes in UC
Aude Bressenot et al.
GUT (2015)
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Christopher D. Buckley et al.
IMMUNITY (2014)
Comparison of experimental mouse models of inflammatory bowel disease
Soo Youn Oh et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer
Ross Stewart et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Resolution of inflammation: an integrated view
Almudena Ortega-Gomez et al.
EMBO MOLECULAR MEDICINE (2013)
Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23
Jenna L. Cash et al.
EMBO REPORTS (2013)
Understanding Resolvin Signaling Pathways to Improve Oral Health
David Keinan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma
Jun Miyata et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites
Pauline Le Faouder et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease
Angela Sena et al.
PLOS ONE (2013)
Neutrophil recruitment and function in health and inflammation
Elzbieta Kolaczkowska et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Resolvin E1 (RX-10001) Reduces Corneal Epithelial Barrier Disruption and Protects Against Goblet Cell Loss in a Murine Model of Dry Eye
Cintia S. de Paiva et al.
CORNEA (2012)
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
Charles N. Serhan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
The role of neutrophils during intestinal inflammation
B. M. Fournier et al.
MUCOSAL IMMUNOLOGY (2012)
Up-Regulation of Annexin-A1 and Lipoxin A4 in Individuals with Ulcerative Colitis May Promote Mucosal Homeostasis
Linda Vong et al.
PLOS ONE (2012)
Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
Driss El Kebir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn's and ulcerative colitis
F. Averboukh et al.
COLORECTAL DISEASE (2011)
Genetics and pathogenesis of inflammatory bowel disease
Bernard Khor et al.
NATURE (2011)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Resolvin E1, an Endogenous Lipid Mediator Derived from Eicosapentaenoic Acid, Prevents Dextran Sulfate Sodium-Induced Colitis
Tsukasa Ishida et al.
INFLAMMATORY BOWEL DISEASES (2010)
Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
Taisuke Ohira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
Matthieu Allez et al.
JOURNAL OF CROHNS & COLITIS (2010)
Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification
Eric L. Campbell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
I. Arijs et al.
GUT (2009)
Neutrophil apoptosis and the resolution of infection
Adam D. Kennedy et al.
IMMUNOLOGIC RESEARCH (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment
Ingrid Arijs et al.
PLOS ONE (2009)
Apoptosis Is Essential for Neutrophil Functional Shutdown and Determines Tissue Damage in Experimental Pneumococcal Meningitis
Uwe Koedel et al.
PLOS PATHOGENS (2009)
Anti-inflammatory and proresolving lipid mediators
Charles N. Serhan et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Synthetic chemerin-derived peptides suppress inflammation through ChemR23
Jenna L. Cash et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Neutrophil-dependent oxidative stress in ulcerative colitis
Yuji Naito et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2007)
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
Makoto Arita et al.
JOURNAL OF IMMUNOLOGY (2007)
Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
Charles N. Serhan
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Resolvin E2: Identification and anti-inflammatory actions: Pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis
Eric Tjonahen et al.
CHEMISTRY & BIOLOGY (2006)
Lipoxin biosynthesis in inflammatory bowel disease
MJ Mangino et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2006)
Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria
N Kamada et al.
JOURNAL OF IMMUNOLOGY (2005)
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
M Arita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular circuits of resolution: Formation and actions of resolvins and protectins
GL Bannenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
M Arita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Annexin 1 and neutrophil apoptosis
M Perretti et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis
T Scheinin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
M Perretti et al.
NATURE MEDICINE (2002)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Neutrophil apoptosis is delayed in patients with inflammatory bowel disease
AE Brannigan et al.
SHOCK (2000)
Share Paper
